EcoDrugPlus

Ensembl ID : ENSHHUG00000052376
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHHUG00000006042
Gene Symbol: -
Cross references: -
85 Possible Orthologues:

Ensembl ID : ENSHHUG00000052365
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSHHUG00000005985
Gene Symbol: -
Cross references: -
85 Possible Orthologues:

Ensembl ID : ENSHHUG00000026220
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSHHUG00000000927
Gene Symbol: -
Cross references: -
33 Possible Orthologues:

Ensembl ID : ENSHHUG00000000921
Gene Symbol: -
Cross references: -
33 Possible Orthologues:

Ensembl ID : ENSHHUG00000051880
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSHHUG00000051797
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSHHUG00000028040
Gene Symbol: PRKCI
1 Cross references
80 Possible Orthologues:

Ensembl ID : ENSHHUG00000051171
Gene Symbol: RPSA
2 Cross references
499 Possible Orthologues:

Ensembl ID : ENSHHUG00000050806
Gene Symbol: -
Cross references: -
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).